Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers.  The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

Revolution Medicines is seeking a Sr. Financial Analyst to support our growing needs in Development and R&D Finance. The successful candidate will have experience with clinical trials, R&D accruals process, month-end close, financial reporting, SOX, and audit support. This position is based out of our headquarters in Redwood City, CA.

• Reporting to the FP&A Manager and will serve as a critical business partner to Clinical Operations.

• Prepare month-end clinical trial accruals, including review of CRO reports, patient costs, and site payments.

• Prepare monthly and quarterly reconciliations for accrued clinical and related prepaid accounts.

• Review contracts and amendments to analyze and determine impact on clinical accruals.

• Work with external CROs and vendors to ensure that expenses are accurately accounted for.

• Ensure and maintain proper documentation and internal controls around clinical trial accruals for SOX compliance.

• Partner with accounting team to support monthly and quarterly close activities.

• Support the annual audit and quarterly reviews through preparation of audit schedules and other documentation as requested by external auditors.

• Help with variance analysis of actuals to budget, explain, and investigate any major discrepancies, and understand key business drivers.

• Review Purchase Order requests.

• Prepare ad hoc financial analysis and analytical support as needed.

Required Skills, Experience and Education:

• Bachelor’s degree in finance, Accounting, or related field.

• Biotech or Big 4 Accounting experience.

• Highly proficient in Excel and strong attention to detail.

• Prior ERP and financial systems experience: Sage Intaact, Netsuite, etc.

• Strong work ethic and ability to adjust workload based on changing priorities.

• Excellent written and verbal communications.

Preferred Skills:

• CPA or MBA.

• Minium 3-5 years’ experience in Big 4 or biotechnology industry.

• Strongly prefer experience in reviewing clinical contracts (i.e. CRO contracts, Site contracts, protocols, etc.).

• Prior experience with clinical trial accruals.

• Adaptive Planning (Office Connect) experience a plus.

• Coupa experience a plus.

The base salary range for this full-time position is $138,000 to $172,000 for candidates working onsite at our headquarters in Redwood City, CA. The range displayed on each job posting is intended to be the salary for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our salary ranges are determined by role, level, and location. Individual pay is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.

Please note that base salary is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.

Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].

#LI-Hybrid   #LI-DN1